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Abstract Page 
 
 Outlined in this paper is a series of work done towards the construction of 
bicyclo[2.2.2]diazaoctane structures found in a several natural products. Detailed work is shown 
for a general method of creating these cores by a domino sequence to rapidly generate these 
cores with enantio- and diastereoselectivity. A similar sequence this outlined and displayed in the 
formal synthesis of brevianamide B. This synthesis makes use of a similar domino sequence, but 
a new source of facial selectivity is used.   
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Honors Thesis Chapter 1: An Introduction to the Bicyclo[2.2.2]Diazaoctane Cores 
 
Introduction 
 
 A number of natural products belonging to a family of reverse prenylated indole 
alkaloids have received interest due to the presence of a bicyclo[2.2.2]diazaocatne core. There 
are approximately 70 molecules in the family with the most notable members being the 
brevianamides, stephacidins, malbrancheamides, notoamides, and 
paraherquamides as seen in Figure 1.1 This structure presents a 
challenge for synthetic chemistry that there is no readily available 
solution, making it a desirable target for efforts in synthetic chemistry.  These molecules are not 
only interesting from a chemical perspective, but from the prospective of a biologist as well due 
to the potent activity these molecules have demonstrated in nature. Both breviamaindes A and D 
have been shown to have modest insecticidal and antifeedant properties.2 Additionally, the 
paraherquamides have been shown to display potent anithelmintic activity and are currently 
under study as treatments for intestinal parasites. An analog of paraherquamide A, 2-
deoxyparaherquamide is currently on the market as an antihelmintic for livestock.1 Perhaps most 
notably in this family, both the notoamides and stephacidins have been shown to have potent and 
selective antitumor activities, where the notoamides have been demonstrated to work against 
HeLa cancer cell lines.3  
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Figure 1. Selected molecules containing a bicyclo[2.2.2]diazaoctane core  
 
Isolation and Biological Activity 
The first member of this family to be discovered was brevianamide A by Birch and co-
workers in 1969 as a metabolite in the fungus Penicillium brevicomactum. Subsequently 
brevianamides B-F were also isolated in the same fungus, although C and D were found to be 
photochemically derived products of isolation rather than synthesized naturally.2 The 
paraherquamides were later isolated in 1980, followed by the stephacids in 2005, and the 
notoamides in 2007.1,2 Most recently the chrysogenamides have been isolated in china in 2008.1   
Biosynthesis 
 In addition to this family’s biological activities and chemical structure, these molecules 
are notable due to their proposed biosynthetic route. There is reasonable evidence that these 
molecules arise from an enzyme catalyzed Diels-Alder reaction. While this reaction is commonly 
employed in organic synthesis and has been known to occur in nature without enzyme activity, 
there are very few cases where a “Diels-Alder-ase” is used in nature. Because all members of 
this family of molecules have been isolated in an enantiopure form, the reaction is likely to be 
stereo and enantio-controlled, suggesting the possible use of an enzyme. 
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Scheme 1. Birch’s Original Proposed Biosynthesis 
 
Shown in Scheme 1 is the original biosynthetic route proposed by the Birch first put 
forward shortly after its isolation.2 The compound brevianamide F is thought to arise from the 
combination of L-tryptophan and L- proline. Reverse prenylation of this intermediate would give 
rise to the intermediate deoxybrevianamide E. This intermediate would then be oxidized and 
undergo the proposed intramolecular Diels-Alder reaction (IMDA) to give a racemic mix of 
products. After oxidation, these intermediates would then undergo a pinacol rearrangement to 
give both brevianamides A and B. In vitro calculations of the four possible transition states of the 
Diels-Alder reaction showed that the energy transition states of the products which had the same 
stereochemistry as brevinamide A and B had the lowest energy associated with them. 
Additionally it showed that the product corresponding to brevinamide A had a lower energy 
transition state than that corresponding to brevinamide B.5 This data potentially shows why 
brevianamide A is the major metabolite in nature. 
8 
 
Feeding experiments with tritium labeled precursors confirmed that both brevianamide F 
and deoxybrevianamide E are intermediates in the synthesis of brevianamides A and B. 
However, these experiments also proved that Birch’s original proposed cycloadducts were not a 
part of the actual biosynthetic route.6 This does not exclude the possibility of the IMDA. A 
revised route by the Williams group shows very similar steps in a slightly different order 
(Scheme 2).2 While the original proposed route for brevianamides A and B was proven to be 
incorrect, it should be noted that when L-proline is replaced with L-isolucine, the route could 
potentially still hold true for paraherquamide A as the proposed cycloadduct was shown to be 
incorporated in feeding studies.  
Scheme 2. Williams’ Revised Biosynthesis    
 Further studies have shown that both brevianamide F and deoxybreviamaide E are 
precursors to not just the brevianamides, but the stephacidins and notoamides as well, and are 
proposed to be involved in the biosyntehsis of the malbrancheamides.1 In other studies it was 
seen that labeled stephacidin A was incorporated into notoamide B.4 It can be concluded from 
these results that both of these molecules likely have their diazaoctane cores constructed in a 
similar manner to the brevianamides.7 Extensive studies have been done in order to isolate the 
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gene cluster involved in the synthesis of the notoamides and stephacidins. Bioinformatic analysis 
revealed a total of 18 genes (NotA - NotR) to be involved on this pathway. Two proteins of note 
from this gene cluster are NotE which is responsible for the condensation reaction between 
tryptophan and proline to create brevianamide F, and NotF which reverse prenylates the indole 
of tryptophan to give deoxybrevianamide E. The presence of the bicyclo[2.2.2]diazaoctane core 
is almost exclusively in Aspergillus and Penicillium, two closely related fungi genuses.1 
Scheme 3. Enzymes Involved in Biosynthesis 
 
Current Strategies to Make the Desired Core 
 Currently there are five strategies that have been employed to make the desired [2.2.2]-
diazaoctane core. The biomimetic Diels-Alder employed by the Williams and Liebscher groups,9 
the radical cyclization by the Myers group,12 oxidative enolate coupling by the Baran group,13 
the cation-olefination cyclization route used by the Simpkins group,15 and finally the SN2’ 
reaction also used by the Williams group.8,15  
 The first strategy discussed used a biomimetic Diels-Alder reaction, which greatly 
resembles the proposed biosynthesis from the Birch group. Starting from the proposed 
biosynthetic intermediate deoxybrevianamide, Williams forms an exocyclic diene in two steps, 
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which under basic conditions isomerizes to form the required endocyclic intermediate for the 
IMDA to take place. The resulting intermediates 19 and 20 correspond directly to the  
Scheme 4. Williams IMDA 
                                           
biosynthetic route proposed by Birch, and similarly were made to undergo an oxidation and 
pinacol rearrangement to form brevianamide B.  While this strategy was effective at creating a 
reactive diene for 4+2 cycloadditions, there is no facial or diastereoselectivity, resulting in a 2:1 
ratio of racemic diastereomers to be produced. Unfortunately, the minor diastereomer was 
required to form the desired natural product. While the cycloaddition was not selective, the 
synthetic route did demonstrate the viability of the Diels-Alder reaction if facial selectivity could 
be controlled. A very similar intermediate was produced during Williams’s synthesis of 
VM55599, a related structure. However, after the same IMDA, a total of 4 diastereomers were 
generated due to the presence of a methyl group on the proline ring.9 
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Figure 2. VM55599 Cycloadducts 
 
After these initial attempts at synthesizing VM55599 by Williams and co-workers, Liebscher and 
co-workers used the same Diels- Alder precursor as Williams and showed that under different 
non-basic conditions, an IMDA reaction could be used to generate exclusively the diastereomer 
26 by using acetyl chloride as a solvent and refluxing for 20 days. 10 
 The next synthetic strategy demonstrated was by the Myers group in their synthesis of 
stephacidin and its dimer avrainvillamide (Scheme 5.)12 Starting from a known achiral 
cycloexanone derivative, a stereocenter was set using a Corey-Bakshi-Shibata (CBS) catalyst. 
That single stereoisomer was used to impart selectivity in all subsequent reactions. Since the 
absolute stereochemistry of stephacidin was unknown at the time, a random catalyst was picked 
to give the (-) enantiomer. After reaching intermediate 26, the key radical cyclization was 
employed. Using tert-amyl peroxybenzoate as an initiator, the aminoacyl radical shown was 
formed according to precedent.11 After elimination of the 1-methyl-2,5-cyclohexadiene radical 
precursor as toluene, the radical then attacked the more substituted carbon of the enamide C-C 
double bond as Baldwin’s rules would predict, causing the expulsion of a phenylthiyl radical. 
While the key core-forming step had a yield of only 62%, the reaction did give an enantiopure 
product.   
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Scheme 5. Myers Radical Cyclization 
  
While this synthesis demonstrated a powerful technique in creating the desired bridged structure, 
it has a minor weakness in that it requires extra steps for the construction of the ring. The 
sequence required the addition of both the thiophenol group as well as the radical precursor in 
order to initiate the key step.12 
 The third strategy, oxidative coupling, was employed towards these molecules by the 
Baran group, and was utilized in their total synthesis of the stephacidins.13 After failing to 
produce the desired core with an intramolecular Diels-Alder, the Baran group decided to turn 
towards chemistry the lab had previously explored.  Previous work in the Baran group had 
demonstrated the ability to couple enolates of carbonyl compounds with indoles and pyrroles. 
While indole coupling would be undesirable in this case, they succeeded in demonstrating that 
the enolates from an ester and amide could be coupled together as well. Starting from CBz 
protected tryptophan 29, the intermediate 31 was produced in three steps (Scheme 6). Using 
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methodology from Seebach for asymmetric alkylation of amino acids, the proline derivative 32 
was formed. The two fragments were then joined together using BOP-Cl as a peptide coupling 
agent to produce the required ester and amide for oxidative coupling to occur.  
Scheme 6. Baran Oxidative Coupling 
 
In the key ring forming step, a multivalented iron complex Fe(AcAc)3  was used in order to 
coordinate the amide and ester together. This combined with the Thorpe-Ingold effect from the 
quaternary proline carbon was thought to drive the reaction forward.  While the exact mechanism 
of the coupling is unknown, the Baran group did offer several potential explanations ranging 
from a concerted ionic rearrangement to the formation of a diradical intermediate (Figure 3.)13 
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Figure 3.Potential Mechanisms for Oxidative Coupling 
 
The Williams group executed another synthetic strategy for constructing the desired 
diazoctane core (Scheme 7). This strategy employs an SN2’ ring closing step, and was used in 
the first total synthesis of brevianamide B.14  Williams starts with a chiral starting material 
generated according to procedures developed by Seebach and converts it in three steps to an 
intermediate containing a diketopiperazine (DKP) core and a p-methoxybenzyl (PMB) group on 
one of the nitrogens. Ten steps later, the molecule contained the proper functionality to undergo 
the SN2’ ring closing step. 
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Scheme 7. Williams SN2’ 
 
The desired material 46 was produced along with the undesired diastereomer 47 in a ratio of 2:1 
with a yield of 62% overall. Treatment of the desired diastereomer with HCl and H2O served to 
remove the N-t-BOC protecting group on the indole as well as to facilitate the cationic 
cyclization to form the final ring structure. The material was then oxidized using m-CPBA, and 
made to undergo the pinacol rearrangement as proposed by Birch in his original biosynthetic 
scheme, leaving only the removal of a protecting group to give brevianamide B. The synthesis 
was a total of 21 steps long from commercially available proline. 
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The SN2’ cyclization demonstrated a variety of possible products based on the 
temperature and solvent conditions. Most notably, when the reaction took place with NaH in 
benzene at elevated temperatures, the undesired product was produced almost exclusively (97:3 
ratio).  However in the presence of 18-crown-6 ether, the selectivity was reversed, giving a ratio 
of 3.85:1 in favor of the desired diastereomer 46.  
The authors proposed that in the absence of a cation complexing agent, the steric 
interactions between the allylic chloride and the p-methoxybenzyl group force the allylic 
chloride over the enolate formed during cyclization. In addition, the chloride ion and the sodium 
ion associated with the enolate would have stabilizing interactions, further selecting for the 
undesired epimer. However, in the presence of a good cation complexing agent, it was suggested 
that the crown ether sodium complex would generate a much larger amount of steric hindrance 
compared to the p-methoxybenzyl group, selecting for the other epimer. The employment of this 
cyclization demonstrated the use of crown ethers in generating facial selectivity in SN2’ 
reactions. 14 
 The final strategy employed initially looks similar to the Williams group SN2’ synthesis. 
However, rather than using an SN2’ reaction to initiate the ring closure, the Simpkins group 
demonstrated a cationic cascade sequence.15 The route shown below was used to form two rings 
in the fused system after generating a single cation, which is passed through the molecule 
through intramolecular transfer events (Scheme 8.) Simpkins starts from diastereopure 48, which 
is a single step away from commercially available proline.16  
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Scheme 8. Simpkin’s Cationic Cyclization 
 
Despite the large amount of complexity built in a single step, the key cationic cascade produced 
a good yield of 82%. Additionally, it was found that facial selectivity could be imparted on the 
reaction based on the stereoisomer at the prenylated position, much like what was seen in the 
Baran strategy. This key step allowed the Simpkins group to develop the shortest currently 
recorded route to brevianamide B in only 9 steps.  However, despite its brevity, the synthesis is 
not without its drawbacks. The diastereoselectivity at the C6 position seemed to depend on the 
steric bulk of the protecting group associated with the amide, as an erosion of selectivity was 
observed when moving from a PMB group, which gave a single diastereomer, to the OBn group 
which gave a 4:1 mixture of diastereomers.15 
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Conclusion 
While all of the routes shown successfully afforded the desired diazaoctane core, there is still 
room for improvement. Each synthesis was highly specific to the construction of that molecule. 
None of the strategies shown could be easily generalized to address the problem of making a 
whole family of molecules containing the core. These routes also tended to be very linear rather 
than convergent in nature. It was noted that reaction schemes that employed cascasde reactions 
of multiband forming reactions were more efficient. Our work was motivated by a desire to 
design a more general route for constructing the core with diastereo- and facial selectivity.  
Table 1. A Comparison of Routes 
Author Technique Employed Molecule Longest Linear 
Sequence 
Williams Intramolecular Diels-
Alder 
Brevianamide B 12 steps 
Myers Radical Cyclization Stephacidin A 12 steps 
Baran Oxidative Coupling Stephacidin A 11 steps 
Williams SN2’ Cyclization Brevianamide B 18 steps 
Simpkins Cationic Cascade 
Sequence 
Brevianamide B 9 steps 
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Honors Thesis Chapter 2: An Efficient Strategy for the Formation of 
Biocyclo[2.2.2]Diazaoctane Structures 
 
Introduction 
 
  Based on previous syntheses, it was clear that a more general strategy for preparing the 
key [2.2.2] diazaoctane core was required. In response to this need we began work on a novel 
domino reaction sequence consisting of an aldol condensation, an isomerization, and 
intramoleuclar Diels-Alder reaction (IMDA.)1,2 The potential of this sequence was first 
demonstrated during the work of Stephen Laws in his attempts to make malbrancheamide B 
(Scheme 2 vide infra). The initial hope was to use an aldol condensation reaction to create an 
exocyclic diene which would then isomerize to create the endocyclic intermediate under basic 
conditions. This intermediate would then be able to participate in an IMDA to create the desired 
ring.  
Methods 
Scheme 1. Chiral Diketopiperazine Core 
                     
Diketopiperazines (DKP) 2 and 3 were produced according to Scheme 1 from commercially 
available N-chloroacyl L-serine methyl ester as a pair of separable diastereomers.3 The absolute 
stereochemistry of these substrates was confirmed by x-ray crystallography. Substrate 3 was then 
submitted to basic conditions in the presence of aldehyde 4 in the hopes that it would undergo 
the reaction sequence described above. It was expected that each step of the reaction would occur 
in a stepwise manner. 
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Scheme 2. Initial Evidence for Domino Sequence 
 
To our delight the condensation intermediate underwent the subsequent isomerization and [4+2] 
cycloaddition in the same reaction vessel (scheme 2). Additionally, the chiral phenyl aminal 
functionality provided good facial selectivity, giving product 5 as a single diastereomer (dr 95:5). 
The steric bulk of the phenyl group was able to direct the dienophile to approach from the 
opposite face, giving the major diastereomer. Since the dienophile group was tethered to the 
molecule, there were no issues with regioselectivity.  
 While a simple NaOMe/MeOH solution was effective at driving the domino sequence 
with aldehydes which did not contain enolizable protons, new conditions needed to be 
determined for enolizable substrates (Scheme 3.) Certain substrates such as aldehyde 4 were 
compatible with a sodium methoxide solution, aldehydes which had enolizable protons would 
self condense under these conditions. 
Scheme 3. Conditions for the Domino Sequence
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By controlling the order of the 
addition of reagents, the domino 
sequence could still continue. 
Addition of LiHMDS to a solution of 
DKP at -78oC provided exclusive 
enolization of the desired material, 
rather than the aldehyde. The resulting 
alcohol was then acetylaed with 1.3 
equivalents (-78 oC  rt) of acetic 
anhydride. Addition of DBU, an 
organic base, would then drive the 
elimination of the acetyl group and 
isomerization to the endocyclic diene.  
While the previous steps occurred 
relatively rapidly, heating overnight at 
90 oC was required to drive the Diels-
Alder cycloaddition reaction to 
completion.  
Results 
 The two conditions were then 
applied towards the substrates shown 
in Table 1.  
With these two sets of conditions, it 
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shown that the strategy was applicable to a variety of functionalities and gave us the ability to 
construct a variety of ring sizes, from five membered rings to the seven membered ring made in 
the initial example. Additionally, it was observed that alkynes were capable of cycloadditions as 
well. While good selectivity could be obtained for all substrates, there was a decline noted for the 
3,3-dimethyl-hexenal substrate. It was noted that reactions performed under conditions B 
generally gave lower yields than those obtained under conditions A.  
Discussion 
 There are several strong points to the described strategy that make it a potent response to 
the problem of constructing the bicyclo[2.2.2]diazaocatne core. The Diels-Alder reaction has 
always been desirable due to its ability for form two bonds simultaneously. The reaction is able 
to generate the desired core structure with good enantioselectivity as well as diastereoselectivity 
due to the chirality of the phenyl aminal group. Additionally, the reaction has the advantage of 
taking place in a single reaction vessel, which allows rapid generation of a large amount of 
complexity. While our synthesis does bear strong similarities to IMDAs employed the by the 
Williams group, there are key differences which distinguish the two. This is most apparently 
seen in the Williams synthesis of malbrancheamide B with our own strategy (Scheme 4).4, 5 
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Scheme 4. A Comparison Between the Williams and Scheerer Route 
 
 Williams’s strategy involves constructing the molecule in a completely linear fashion, while our 
strategy allows for variable aldehydes to be condensed onto a DKP core which can have different 
functionalities installed on it, increasing the ease of generating analogs of the molecule. This 
more convergent synthesis has an advantage over linear ones due to its increased yield and the 
relative ease in constructing smaller fragments separately rather than a large molecule. By 
separating a molecule into smaller fragments, different functionalities can be installed without 
worry about more distant functionalities located on other fragments. Furthermore, it takes three 
separate steps with the Williams route to form the DKP core, the diene precursor, and finally 
undergo the Diels-Alder reaction. Our route reduces this time intensive strategy to a single     
one-pot reaction. Finally due to the presence of a chiral aminal auxiliary, facial selectivity allows 
the synthesis of enantiopure material. 
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 However, our route is not without its flaws. While good facial and diasteroselecivity 
were shown during all model reactions, during our application towards the total synthesis of 
malbrancheamide B, there was a degradation of selectivity. It was seen that while the chiral 
aminal could still generate good facial selectivity, the dr: declined from 95:5 to 2:1, giving the 
“syn” product over the “anti.” These results are consistent with previous work done by the 
Williams group with the model system and the IMDA used in their synthesis of brevianamide B 
shown in Scheme 4. The anti and syn relationship in this case refers to the endo and exocyclic 
orientations of the IMDA reaction, with the endo product corresponding to the anti configuration 
(Scheme 5). It was seen during trial runs of the synthesis that after the addition of the indole, the 
anti-selectivity was unobtainable. In fact, after addition of the indole, the system was shown to 
give a ratio of 2:1 in favor of the syn product.   
Scheme 5. Effects of an Indole Diastereoselectivity 
     
It was theorized that the added rigidity of the indole system was responsible for this change in 
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selectivity. Comparison between the model shown and other models generated by the Williams 
group demonstrated that the gem dimethyl groups had a negligible effect on selectivity, leaving 
the indole responsible for the undesired syn bias. Ab initio calculations later showed that in the 
presence of the indole there was a 1.2 kcal/mol difference in energy favoring the syn relationship 
while in the model system, anti-stereochemistry was favored by 4-7 kcal/mol.  Comparing our 
work with the IMDA reactions employed by Williams in his syntheses of brevianamide B shows 
that while our reaction imparted facial selectivity, the diastereoselectivity was comparable to 
achiral analogs. Another drawback of the route is one that is intimately tied to one of its 
successes. While the chiral phenyl aminal provides good facial selectivity of the reaction, it is 
not present in any of the structures containing the diazaoctane core. This means that it must be 
removed eventually. Although there is precedent for easy removal of the aminal chiral auxiliary 
by reduction, the methods proved to be harsh on other functionalities on the molecule, requiring 
additional steps in order to remove.  
Conclusion 
 Outlined in this chapter was an efficient way to generate a large amount of complexity in 
the form of a bicyclic[2.2.2]diazaoctane core from a one-pot domino reaction. Good 
enantioselectivity could be imparted on the molecule from a chiral phenyl aminal auxiliary. The 
sequence showed a wide range of applications by creating three different ring sizes as well as 
proving accessible to alkynes. The route showed competitive results with all other strategies 
currently available to make the desired core due to its enantioselectivity and amount of 
complexity generated in a single step. This synthetic strategy should be applicable towards a 
wide range of biologically active molecules containing the signature bicyclo[2.2.2]diazaoctane 
core.  
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Experimental Procedures 
 
 
 
 
 
Diketopiperazine lactim methyl ether 2, 3. To N-chloroacyl L-serine methyl ester8 (4.5 g, 
22.8mmol) in toluene (220 ml) at rt was added benzaldehyde dimethyl acetal (2.9 ml, 27.4 
mmol) and p-toluenesulfonic acid monohydrate (108 mg, 0.57 mmol). The solution was heated at 
reflux for 16 h with a Dean-Stark trap. After cooling to rt, the solution was diluted with saturated 
aqueous NaHCO3 (2 x 50 ml). The organic layer was removed and the aqueous portion extracted 
with Et2O (75 ml). The combined organic layers were washed with brine (50 ml), dried with 
Na2SO4, and concentrated in vacuo. The viscous product was purified by flash column 
chromatography on silica gel (elution: 10% to 60% EtOAc in hexane) to afford a yellow oil 
(5.48g, 19.23 mmol, dr ca. 2:1). This intermediate product was dissolved in butanone (110 ml), 
sodium azide (2.50 g, 38.5 mmol) was added, and the heterogenous mixture was heated to 80 °C 
for 15 h. After cooling to rt, the mixture was concentrated to a syrup and diluted with a 
halfsaturated 
NaCl solution (100 ml) and extracted with Et2O (3 x 50 ml). The combined organic 
phases were dried with Na2SO4, and concentrated to afford a reddish-brown oil (5.34 g, 18.3 
mmol). This intermediate azide product was used without purification in the subsequent 
Staudinger reduction. After dissolving the intermediate azide product (2.3 g, 7.9 mmol) in 
toluene (45 ml), resin-bound triphenyl phosphine (3.3 g, ~10.0 mmol) was added at rt. The 
mixture was stirred for 10 min at rt until gas evolution steadied and was heated to 90 °C for 20 h. 
Additional resin-bound triphenyl phosphine was added (0.5 g), until consumption the starting 
material was apparent by TLC. After cooling to rt, the phosphine resin was removed by vacuum 
filtration. The filtrate was concentrated and purified by flash column chromatography on silica 
(elution: 30% to 100% EtOAc in hexane) to afford product 2 (0.88 g, 36% yield, 3 steps) as a 
colorless solid and 3 (0.44 g, 19% yield, 3 steps) as a light yellow oil: 2: mp 133 °C; TLC (60% 
EtOAc in hexane), Rf: 0.15 (KMnO4); [α]D25 = –63.2° (c = 2.02,CH2Cl2); IR (film) 3022, 
2948, 2872, 1684, 1559, 1361, 1265, 1185, 1048, 934, 760 cm–1; 1HNMR (400MHz, CDCl3) 
7.37 (m, 3H), 7.29 (m, 2H), 6.25 (s, 1H, C8H), 4.49 (m, 1H), 4.31 (m,1H), 4.28 (d, J = 19.5 Hz, 
1H), 4.12 (dd, J = 19.9, 3.9 Hz, 1H), 4.04 (t, J = 9.0, 1H, C6H), 3.83 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 166.0, 161.3, 136.9, 129.6, 128.9, 126.8, 90.2, 65.7, 55.1, 54.1, 53.6; Exact mass 
calcd for C13H14N2O3Na [M+Na]+, 269.0897. Found 269.0892. 
X-ray structure. 
 
3: TLC (60% EtOAc in hexane), Rf: 0.20 (KMnO4); [α]D25 = –107° (c = 2.30, CH2Cl2); IR 
(film)2993, 2950, 2892, 1704, 1438, 1338, 1315, 1224, 1113, 1011, 850, 769 cm–1; 1H NMR 
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(400MHz, CDCl3) 7.50 (m, 3H), 7.40 (m, 2H), 6.50 (s, 1H, C8H), 4.49 (dd, obs triplet, J = 6.6 
Hz, 1H), 4.37 (m, 1H), 4.23 (s, 2H), 3.88 (t, J = 9.0 Hz, 1H, C6H), 3.76 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 165.4, 158.6, 138.2, 129.3, 128.8, 126.5, 88.9, 69.4, 54.3, 53.8, 52.2; Exact mass 
calcd for C13H14N2O3Na [M+Na]+, 269.0897. Found 269.0901. 
 
General conditions A for aldol condensation / alkene isomerization / DKP Diels-Alder 
cycloaddition. To diketopiperazine 2 (0.2–0.3 mmol) in methanol (1.0–2.0 mL, degassed with 
nitrogen) at rt was added the dieneophilic aldehyde substrate (1.2–1.3 equiv) and a freshly 
prepared solution of sodium methoxide (3 equiv, 0.45–1.0 mL, 2.0 M). The reaction mixture was 
heated to 65 °C for 16–24 h. After cooling to rt, the reaction mixture was diluted with sat. 
aqueous NH4Cl (10 mL) and extracted with EtOAc (3 x 10 mL). The combined organic layers 
were washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo. 
General conditions B for aldol condensation / alkene isomerization / DKP Diels-Alder 
cycloaddition. To diketopiperazine 2 (0.2 mmol) in toluene (2 mL) at –78 °C was added 
LiHMDS (1.0M in THF, 1.1 equiv) dropwise over 5 min by syringe. After stirring for 15 min at 
–78 °C, the aldehyde substrate (1.1–2 equiv) was added to the solution. After stirring for an 
additional 15 min at –78 °C, Ac2O (1.3 equiv) was added and the cooling bath removed. The 
reaction mixture was stirred at room temperature for 1–2 h. DBU (2 equiv) was added and the 
reaction was heated to 90 °C for 16–24 h. After cooling to rt, the reaction mixture was diluted  
with sat. aqueous NH4Cl (20 mL) and extracted with EtOAc (3 x 15 mL). The organic layers 
were combined, washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo 
 
 
 
Cycloadduct 5. Prepared according to general procedure A. To a solution of compound 2 (40.4 
mg, 0.25 mmol) in methanol (2.0 mL) under nitrogen was added salicaldehyde 4 (57.1 mg, 0.23 
mmol) and sodium methoxide (0.37 mL, 2M, 0.75 mmol). The reaction vessel was fitted with are 
flux condenser and heated to 65 °C. After stirring at reflux for 21 h, the mixture was cooled to 23 
°C, diluted with sat. aqueous NH4Cl and extracted with EtOAc (4 x 15 mL). The combined 
organic layers were washed with brine, dried with sodium sulfate, and concentrated in vacuo. 
The unpurified product was a single diastereomer as judged by 1H NMR. Purification by flash 
chromatography on silica gel (elution: 20% to 60% EtOAc in hexane) afforded product 5 (68.7 
mg, 76% yield) as a colorless amorphous solid: TLC (40% EtOAc in hexane), Rf: 0.40 (CAM); 
[α]D25 = –75.3° (c = 0.77, MeOH); IR (film) 2948, 2865, 1691, 1633, 1490, 1289 cm–1; 1H 
NMR (400 MHz, CDCl3) 7.38–7.35 (m, 3H), 7.32–7.28 (m, 3H), 7.18 (t, J = 7.4 Hz, 1H), 7.05 
(t, J =7.4 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 6.26 (s, 1H), 4.51 (d, J = 9.3 Hz), 4.06 (dd, J = 11.7, 
3.9 Hz, 1H), 4.02 (d, J = 9.4 Hz, 1H), 3.63 (s, 3H), 3.49 (d, J = 14.9 Hz, 1H), 3.42 (d, J = 14.9 
Hz, 1H), 3.28 (t, J = 11.7 Hz, 1H), 2.77 (m, 1H), 2.35 (dd, J = 12.9, 9.8 Hz, 1H), 1.00 (dd, J = 
12.9, 4.7 Hz, 1H); 
29 
 
13C NMR (100 MHz, CDCl3) δ 170.5, 168.9, 159.0, 136.4, 132.5, 131.3, 129.2, 
128.5, 127.5, 126.3, 123.9, 120.2, 88.4, 70.7, 67.2, 66.0, 62.5, 54.5, 43.0, 36.6, 32.9); HRMS 
(ES+): Exact mass calcd for C23H22N2O4Na [M+Na]+, 413.1472. Found 413.1470. X-ray 
structure. 
 
Salicaldehyde allyl ether 4 was prepared by alkylation of salicaldehyde.9 
 
 
 
 
Cycloadduct 7. Prepared according to general procedure A. The unpurified product was a 90:10 
mixture of diastereomers as judged by 1H NMR. Purification by flash chromatography on silica 
gel (elution: 15% to 60% EtOAc in hexanes) afforded product 7 as a white solid (76.8 mg, 68% 
yield): mp 165.4–168.0 °C; TLC (30% EtOAc in hexane), Rf: 0.25 (CAM); [α]D25 =+21.5° (c = 
0.12, CH2Cl2); IR (film) 3359, 2946, 1684, 1632, 1495, 1453, 1409, 1582, 1337,1253, 1212, 
763, 742; 1H NMR (400 MHz, CDCl3) 7.36 (m, 3H), 7.31 (m, 3H), 7.18 (t, J = 7.0 Hz, 1H), 
7.11 (t, J = 7.0 Hz, 1H), 7.04 (d, J = 7.4 Hz, 1H), 6.23 (s, 1H), 4.59 (d, J = 9.4 Hz, 1H), 4.08, (d, 
J = 9.4 Hz, 1H), 3.77 (s, 3H), 3.74 (d, J =18.0 Hz, 1H), 3.33 (d, J = 18.0 Hz, 1H), 2.85 (dd, J = 
16.0, 5.1 Hz, 1H), 2.55–2.45 (m, 4H), 1.45 (d, J = 10.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
170.2, 169.5, 136.5, 134.4, 134.2, 129.8, 129.2, 128.5, 128.0, 126.7, 126.3, 126.3, 125.5, 88.4, 
67.4, 66.5, 64.1, 62.9, 54.8, 37.6, 36.3, 34.8, 34.2, 33.; Exact mass calcd for 
(C23H22N2O3Na) [M+Na]+, 397.1523. Found 397.1525. X-ray structure.. 
 
 
 
Allyl benzaldehyde 8 was prepared according to the above scheme.10 
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Cycloadduct 9. Prepared according to a modified general procedure A, whereby additional vinyl 
benzaldehyde substrate 8 (1 equiv, 2.25 equiv total) was added to the reaction mixture after 1 h 
and the solution was maintained at 65 °C for an additional 18 h. The reaction vessel was cooled 
to room temperature and worked up according to the general procedure A. The unpurified 
product was a single diastereomer as judged by 1H NMR. Purification by flash chromatography 
on silica gel (elution: 10% to 40% EtOAc in hexanes) afforded product 9 (49.2 mg, 68% yield) 
as a pale yellow solid: mp 208 °C; TLC (40% EtOAc in hexane) Rf: 0.30 (CAM); [α]D25 = 
+140° (c = 1.70, CH2Cl2); IR (film) 3064, 2950, 2894, 1698, 1639, 1457, 1399, 1369, 1241, 
1199, 1072, 841, 755 cm–1; 1H NMR (400 MHz, CDCl3) 7.37–7.15 (m, 8H), 7.04 (d, J = 7.0 
Hz, 1H), 6.24 (s, 1H), 4.58 (d, J = 9.8 Hz, 1H), 4.11 (d, J = 9.8 Hz, 1H), 3.81 (dd, J = 10.2, 6.3 
Hz, 1H), 3.68 (s, 3H), 3.62 (d, J = 15.6 Hz, 1H) 3.36 (d, J = 15.6 Hz, 1H), 2.57 (t, J = 11.7, 1H), 
1.95 (dd, 
J = 12.5, 6.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 171.4, 142.9, 141.8, 136.3, 129.3, 128.5, 
127.0, 126.5, 125.8, 123.0, 88.58, 88.6, 77.9, 67.1, 65.4, 54.7, 49.8, 36.4, 35.5, 32.2; Exact mass 
calcd for C22H20N2O3Na [M+Na]+, 383.1366. Found 383.1368. 
 
Vinyl benzaldehyde 8 was prepared from 1-bromo-2-vinylbenzene via lithium-halogen 
exchange (n-BuLi) and trapping the derived aryl lithium with DMF.11 
 
 
 
Cycloadduct 11. Prepared according to general procedure A. The unpurified product was a 
single diastereomer as judged by 1H NMR. Purification by flash chromatography on silica gel 
(elution: 20% to 60% EtOAc in hexanes) afforded product 11 (34 mg, 50% yield) as a white 
solid: mp 121.6–123.6 °C; TLC (40% EtOAc in hexanes), Rf: 0.59 (CAM); [α]D25 = +46.3° (c 
=0.88, CH2Cl2); IR (film) 3852, 3748, 2948, 2893, 2863, 1682, 1635, 1558, 1456, 1398, 1353, 
1312, 1216, 1197 cm–1; 1H NMR (400 MHz, CDCl3) 7.35 (m, 3H), 7.26 (m, 2H), 6.18 (s, 1H), 
4.49 (d, J = 9.4 Hz, 1H), 4.01 (d, J = 9.4 Hz, 1H), 3.84 (s, 3H), 2.55 (m, 1H), 2.23 (d, J = 13.7 
Hz, 1H), 2.18 (dd, J = 12.1, 9.4 Hz, 1H), 2.07 (d, J = 13.7 Hz, 1H), 1.73 (dd, , J = 12.1, 7.0 Hz, 
1H), 1.42 (dd, J = 12.1, 4.7 Hz, 1H), 1.22 (s, 3H), 1.21 (m, 1H), 1.13 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 170.1, 169.6, 136.6, 129.1, 128.5, 126.4, 88.2, 77.7, 76.7, 67.0, 64.9, 54.5, 46.1, 
44.4, 43.3, 39.3, 33.7, 31.9, 31.7; Exact mass calcd C20H24N2O3Na [M+Na]+, 363.1679. 
Found 
363.1681. 
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2,2-dimethyl-4-pentenal (10) was prepared according to the above scheme.12 
 
 
 
Cycloadduct 13. Prepared according to general procedure B. The unpurified product was a 
single diastereomer as judged by 1H NMR. Purification by flash chromatography on silica gel 
(elution: 10% to 50% EtOAc in hexanes) afforded product 13 (34.2 mg, 52% yield) as a white 
solid: mp 148 °C; TLC (40% EtOAc in hexane) Rf: 0.30 (CAM); [α]D25 = +118° (c = 0.77, 
MeOH); IR (film) 2923, 2856, 1693, 1637, 1558, 1495, 1456, 1404, 1361, 1208, 1049, 972, 755, 
697, 623 cm–1; 1H NMR (400MHz, CDCl3) 7.34–7.32 (m, 3H), 7.27–7.24 (m, 2H), 6.20 (s, 
1H), 4.51 (d, J = 9.4 Hz, 1H), 4.01 (d, J = 6.6 Hz, 1H), 3.86 (s, 3H), 2.32 (dd, J = 12.5, 9.4 Hz, 
1H), 2.16 (m, J = 13.6, 1H), 2.04 (m, 1H), 1.90 (m, 1H), 1.83–1.63 (m, 5H), 1.24 (m, 1H), 1.19 
(dd, J= 12.5, 4.3 Hz, 1H), 1.09 (J = 12.9, 3.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 171.1, 
169.0, 136.8, 129.0, 128.5, 126.3, 88.3, 67.3, 67.0, 62.9, 54.4, 38.6, 37.3, 30.2, 29.3, 25.4, 21.0; 
Exact 
mass calcd for C19H22N2O3Na [M+Na]+, 349.1523. Found 349.1524. X-ray structure. 
 
5-hexenal13 (18) was prepared from 5-hexen-1-ol by Parikh-Doering oxidation (SO3•pyr, 
DMSO, i-Pr2NEt). 
 
 
Cycloadduct 19. Prepared according to general procedure B. The unpurified product was a 
single diastereomer as judged by 1HNMR. Purification by flash chromatography on silica gel 
(elution: 30% to 80% EtOAc in hexanes) afforded product 19 (20.2 mg, 31.2%) as a white solid: 
mp 132.6–133.8 °C; TLC (60% EtOAc in hexanes), Rf: 0.46 (KMnO4); [α]D25 = +42.7° (c = 
0.80, CH2Cl2); IR (film) 2947, 2869, 1689, 1635, 1558, 1540, 1398, 1353, 1317, 1255, 1212, 
1196, 1018, 915, 759, 736, 697, 621, 551 cm–1; 1H NMR (400 MHz, CDCl3) 7.34 (m, 3H), 7.26 
(m, 2H), 6.19 (s, 1H), 4.51 (d, J = 9.8 Hz, 1H), 4.09 (d, J = 9.8 Hz, 1H), 3.83 (s, 3H), 2.34 (m, 
2H), 2.22 (dd, J = 12.5, 9.5 Hz, 1H), 2.20 (m, 1H), 2.10–1.86 (m, 3H), 1.48 (dd, J = 12.5, 5.1 Hz, 
1H), 1.26 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 170.3, 170.1, 136.6, 129.1, 128.5, 126.4, 
88.4, 76.7, 67.1, 65.2, 54.6, 45.6, 34.1, 30.0, 28.1, 23.6; Exact mass calculated for 
C18H20N2O3Na 
[M+Na]+, 335.1366. Found 335.1364. 
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Cycloadduct 15. Prepared according to general procedure B. The unpurified product was a 
single diastereomer as judged by 1H NMR. Purification by flash chromatography on silica gel 
(elution: 10% to 50% EtOAc in hexanes) afforded product 15 (23.9 mg, 37% yield) as a yellow 
oil: TLC (40% EtOAc in hexane) Rf = 0.40 (CAM); [α]D 
25 = +59° (c = 2.70, MeOH); IR (film) 3312, 3064, 2946, 2864, 2366, 1691, 1559, 1268, 1110, 
1028, 735 cm–1; 1H NMR (400 MHz, CDCl3) 7.33 (m, 3H), 7.26 (m, 2H), 6.26 (s, 1H), 5.86 (s, 
1H), 4.73 (d, J = 9.4 Hz, 1H), 4.31 (d, J = 9.8 Hz, 1H), 3.84 (s, 3H), 2.67 (m, 1H), 2.52–2.36 (m, 
2H), 2.12 (m, 1H), 1.81–1.66 (m, 3H), 1.61 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 174.1, 
169.2, 155.4, 129.2, 128.4, 126.6, 126.1, 87.9, 74.6, 68.6, 66.9, 66.1, 55.7, 26.9, 25.9, 20.9, 19.3; 
Exact mass calcd for C19H20N2O3Na [M+Na]+, 347.1366. Found 347.1355. 
 
 5-hexynal14 (14) was prepared from 5-hexyn-1-ol by Parikh-Doering oxidation (SO3•pyr, 
DMSO, i-Pr2NEt). 
 
 
 
Cycloadduct 17. Prepared according to general procedure B. The unpurified product was a 
85:15 ratio of diastereomers as judged by 1H NMR. Purification by flash chromatography on 
silica gel (elution: 10–50% EtOAc in hexanes) could not separate the diastereomers; product 17 
(31.5 mg, 44% yield) was afforded as a pale yellow oil (data for major isomer): TLC (40% 
EtOAc in hexane); Rf: 0.40 (CAM); [α]D25 = +24° (c = 2.14, CH2Cl2); IR (film) 2951, 
2866,1683, 1639, 1458, 1398, 1353, 1216, 1029, 936, 738 cm–1; 1H NMR (400 MHz, CDCl3) 
7.32 (m,3H), 7.25 (m, 2H), 6.17 (s, 1H), 4.51 (d, J = 9.4 Hz, 1H), 4.04 (d, J = 9.8 Hz, 1H), 3.83 
(s, 3H), 2.51 (m, 1H), 2.22 (dd, J = 10.2, 6.3 Hz, 1H), 2.15 (m, 1H), 2.11 (dd, J = 20.7, 8.6 Hz, 
1H), 1.90 (m, 1H), 1.80 (m, J = 5.1 Hz, 1H), 1.57 (dd, J = 12.5, 6.3 Hz, 1H), 1.04 (s, 3H), 0.87 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.4, 169.4, 129.0, 128.5, 128.4, 128.4, 126.4, 126.0, 
88.2, 77.8, 67.1, 65.9, 55.0, 54.3, 41.7, 39.1, 30.7, 29.5, 27.3, 25.0; Exact mass calcd for 
C20H24N2O3Na [M+Na]+, 363.1679. Found 363.1667. 
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Honors Thesis Chapter 3: Efforts Towards the Total Synthesis of Brevianamide B 
 
An Introduction to Brevianamide B 
 
 After demonstrating the utility of our synthetic strategy discussed in chapter 2, we sought 
to apply our methods towards the total synthesis of the molecule brevianamide B. As previously 
mentioned, brevianamide B is part of a larger family of reverse prenylated alkaloid indoles 
containing a unique bicyclo[2.2.2]diazaoctane core. Brevianamide A was the first member of this 
family of molecules to be isolated in 1969 in the fungi Penicillium brevicomatum by the Birch 
group. Later, brevianamimides B through F were isolated in the same fungus. The brevianamides 
are structurally unique from most other members of the bicyclo[2.2.2]diazaoctane in that the ring 
structure fused to the core has the opposite stereochemistry from most members of the family 
(Figure 1).1 This stereochemistry aligns with the “syn” diastereomer according to nomenclature 
established by Williams.2 Along with most members of this family, brevianamide B displays 
biological activity as an insecticide.3 
Figure 1. Sterochemcial Relationships to the Diazaoctane Core 
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While we had already devised a viable strategy for creating the key diazaoctane core, we 
chose to use the challenges presented by brevianamide B to expand upon our earlier efforts at 
constructing bicyclo[2.2.2]diazaoctane cores. We desired to revise the previous strategy in order 
to overcome the limitations encountered in previous work. Primary, these limitations were a lack 
of diastereoselecivity of the “syn” and “anti” products and the removal of the chiral aminal. With 
this goal in mind, a new strategy was designed where facial would be generated from the 
dieneophile rather than the diene. Conditions for this reaction could largely be kept the same as 
they previously were (scheme 1).  
Scheme 1. Creating an Achiral Azadiene 
 
 By stopping the reaction sequence after the isomerization step, a variety of dienophiles 
with various auxiliaries could be tested in an attempt to generate enantio-, diastereo-, and 
regioselectivity (Figure 1). 
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Figure 1. Potential Diels-Alder Isomers 
 
 
Finding and Effective Diels-Alder Auxiliary 
Lewis Acid Catalysis 
One route which was explored for creating the desired core was the use of Lewis acid 
catalysis to give diastereoselectivity. Diels-Alder reactions result from interactions between the 
highest occupied molecular orbital (HOMO) of the diene and the lowest unoccupied molecular 
orbital (LUMO) of the dienophile. The lower the energy difference between these two transition 
states is, the more favorable the interactions between the molecular orbitals are, which leads to a 
lowering of the activation energy.4 It has long been known that the addition of a Lewis acid to a 
dienophile containing a Lewis basic site would result in the lowering of the energy state of the 
LUMO, thereby allowing more favorable interactions between the HOMO and     
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Figure 2. Decrease in LUMO Energy Values From Lewis Acids                                                                                                                                                                                                                                                     
 
LUMO levels. The lowered energy levels lead to an increase in reaction rates, generating 
products faster, and at lower temperatures. While the increased reaction rate is certainly 
desirable, Lewis acid catalysis is more notable for its increase in diastereoselectivity. While the 
increase in diastereoselectivity has traditionally been explained by increased interactions 
between secondary orbitals (those not involved in bond formation) it has been called into 
question by work done by the Houk group.5, 6 While the exact source of stereoselectivity is not 
known, Lewis acid catalysis is still a powerful tool for generating diastereoselecitve Diels-Alder 
reactions. The Lewis acids explored consisted of LiCl, Sc(Otf)3, and Cu(Otf)2. An alkylated 
oxazolidinone was used as an auxiliary for the dienohpile in order to promote good coordination 
with a bidentate ligand. If success was seen with any of these catalysts in affecting the 
diastereoselectivity, then the Lewis acids associated with chiral ligands would be explored to try 
and enhance the enantioselectivity.7 
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Figure 3. Lewis Acid Catalyzed Diels-Alders 
 
Despite the potential and precedent of Lewis acid catalysis, all Lewis acids explored 
showed no increase in diastereoselctivity by spectroscopic standards.4,5,6 This lack of selectivity 
is likely due to the presence of a Lewis basic site on the diene in addition to the dieonphile. As 
shown in previous schemes, there is a nitrogen atom present in the diene system whose lone pairs 
could potentially act as electron donators to a Lewis acid. Despite the bidentate ligand present on 
the dienophile, it is likely that the Lewis acid coordinated with the diene instead, giving no 
enantioselecitivty.  
Imminium Ion Catalysis 
 In addition to trying Lewis acid catalysis, a set of organic amine catalysts pioneered by 
the MacMillian in the early 2000s were examined (substrates 6 and 7).8 These catalysts consisted 
of series of chiral, enantiopure, secondary amines, which were able to mimic properties of Lewis 
acid catalysis as well as use steric interactions to generate facial selectivity. In the presence of a 
carbonyl, secondary amines will reversibly condense to form imminium ions.   
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Figure 4. Imminium Ion Formation 
                                      
Because the positive charge is connected to the olefin through resonance, the overall electron 
density of the dienophile will decrease, lowering the LUMO energy level much like Lewis acids 
will. In addition to increasing reaction rates, these catalysts also demonstrated the ability 
generate enantioselectivity as well, due to a sterically bulky directing group such as a phenyl 
group. Geminal methyl groups were used on the catalysts in order to direct the formation of the E 
isomer of the imminium ion. A second set of catalysts generated by the Johannes group was 
shown to generate competitive enantiomeric excess despite lacking the germinal methyl groups.9 
Catalysts would follow the general cycle shown in scheme 3.8 
Scheme 2. Catalytic Cycle for Secondary Chiral Amines 
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These catalysts looked especially promising due to a second paper published by the MacMillian 
group detailing the utility of the reaction in 1,3 dipolar cycloadditions with nitrones to form 
nitrogen containing rings similar to the desired diazaoctane core.10 
 However, despite the promise these catalysts presented, they were unable to promote the 
desired Diels-Alder reaction. Despite using conditions optimized by the Macmillan and Johannes 
groups, reactions involving these catalysts did not generate anything which could be identified as 
a cycloaddition product. These reactions either did not consume starting material, or produced a 
series of decomposition products which made interpretation of crude NMRs and separation by 
chromatography impossible. Substrate 6 appeared to generate a small amount of cycloaddition 
product, but it was deemed to be minimal enough that a new pathway needed to be explored.  
Sultam Chiral Auxiliary 
The final auxiliary used was a camphor-derived bornane-10,2 sultam 11. While this 
auxiliary did not have some of the electronic advantages the two previous catalysts discussed 
did, it was desirable for its low cost, ease of preparation (one step from commercially available 
material), and its ease of removal.11,12 Much like the previously explored Diels-Alder auxiliary, 
this substrate was originally designed to work with Lewis acid catalysis by providing two 
chelating sites. However, due to the large steric bulk of the molecule, good facial selectivity 
could be generated regardless of presence of a Lewis acid or not.  
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Scheme 3. Chiral Sultam Diels-Alders  
 To our delight, the sultam auxiliary was able to not only exhibit regioselectivity but 
diastereoselectivity as well. Only a single diastereomer could be seen in the unpurified mixture 
of the reaction spectroscopically. While normally more advanced methods would be required to 
determine the enantiomeric excess, the presence of a single diastereomer was sufficient due to 
the enantiopure sultam. Because the sultam was enantiopure, a change in facial selectivity would 
show up as two diastereomers, rather than the single observed diastereomer.    
Synthetic route 
 With a proper source of selectivity, a full route was finally able to be constructed. 
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Scheme 3. Synthetic Route Towards Brevianamide B  
 
Starting from a DKP core similar to the phenyl aminal auxiliary variant used in previous efforts , 
a Diels-Alder precursor was rapidly constructed using reaction conditions previously explored 
(Scheme 1). 
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Figure 5. Achiral Diketopiperazine Core 
                                   
The azadiene intermediate however proved to be more difficult to work with than was 
initially predicted. The molecule was oxygen sensitive and would decompose if caution was not 
used. In addition, the molecule proved to be sensitive to the mildly acidic conditions of silica gel, 
making chromatography and TLC monitoring methods impossible. Fortunately the substrate 
proved to be crystalline and could be purified by recrystalization. While a maximum yield of 
42% by recrystalization was recorded, it is suspected that this yield could increase with 
subsequent recrystalizations and if exposure to air could be minimized.  
After generating the azadiene diene, the material was submitted to heating conditions for 
24 hours in DMF with the acryloyl sultam chiral auxilarly, giving the desired cycloadduct as a 
single enantiomer and diastereomer. It was originally planned to perform the Diels-Alder 
reaction in the same “pot” that the aldol addition and isomerization took place in. However in the 
presence of the excess DBU needed to drive the isomerization step, the dienophile would add in 
a Michael addition, rather than the desired cycloaddition (Figure 6). 
Figure 6. Michael Addition Product   
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The Michael addition was seen to occur with as little as 1.2 equivalents of base present. Because 
of this undesired product, the one-pot reaction sequence from previous work was not entirely 
applicable in this scenario. The azadiene could also be submitted to similar conditions with 
achiral dienohpiles. The substrate showed reactivity with both benzyl and ethyl acrylate to 
generate racemic cycloadducts. These products showed a 3:1:1 ratio of the potential 4 
diastereomers as determined by NMR spectroscopy. While separation of these diastereomers was 
possible for cycloadducts derived from ethyl acrylate, the benzyl acrylate cycloadducts proved 
inseparable, making it impossible to get an accurate yield of a single diastereomer. Yields for the 
major diastereomer of the ethyl cycloadduct were seen to be lower than yields from the chiral 
sultam reactions (48% vs. 62%) However, the yield of all diastereomers together (64%) gave an 
almost equivalent amount, showing equal reactivity across substrates, but not equal selectivity.  
The sultam cycloadduct was then submitted to a solution of n-BuLi and benzyl alcohol to 
produce either an ethyl ester or benzyl ester. Initial efforts to convert the sultam cycloadduct to 
the benzyl ester proved to be difficult. It was found that small amounts of ethyl acetate from 
purification steps would lead to a mixture of the benzyl and ethyl esters. In an attempt to avoid 
this issue, efforts were made to convert the sultam to the ethyl ester instead. While these efforts 
proved to be mildly successful, it was ultimately decided to use the benzyl ester in the final 
synthesis as attempts to generate the ethyl ester appeared to give a greater ratio of unwanted 
products. It should be noted that both products could still successfully generate 15. However the 
benzyl ester proved to have problems of its own. Due to the unique solubility of benzyl alcohol it 
is largely soluble in both organic solvents and water. This made quenching and extracting 
reactions difficult, as a large portion of the product would be unrecoverable from the aqueous 
layer. After trying a variety of solvents to extract the organic product from the aqueous layer, it 
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was eventually found that extracting from a brine solution directly could give a good unpurified 
yield from extractions. It is not understood why benzyl alcohol is significantly more soluble in 
the NH4Cl solution rather than a NaCl solution. It was thought that this issue could be 
circumvented entirely by converting the sultam directly to substrate 15 by adding in two 
equivalents of a nucleophilic methyl organometalic. This would simultaneously shorten the 
synthetic route as well as avoid low yields from the transesterification reaction. However 
MeMgBr proved to be insufficient to generate the tertiary alcohol directly from the sultam 
cycloadduct and LiMe led to decomposition of the molecule.  
 The ester was then reacted with two equivalents of methyl Grignard reagent in order to 
create tertiary alcohol 15. Finally, exposure of 15 to HCl effectively generated a carbocation, 
which then underwent an electrophilic addition to the indole to form the six membered ring. This 
final step successfully formed the molecule “pre-brevianamide,” an intermediate used during the 
Williams synthesis which utilized the biomimetic Diels-Alder. Although the final two steps 
followed precedent set by the Williams group, we were unable to generate the final product. 
Williams uses m-CPBA to generate an epoxide, which can undergo a pinacole rearrangement to 
give the natural product. While NMR spectroscopy determined that the epoxided formed well, 
the pinacole rearrangement proved difficult to perform.   
Discussion 
 The synthetic route displayed has several key advantages which make this strategy 
preferable to others employed to make the diazaoctane core. While the key ring forming step 
does not take place in a single flask like previous work showed, the domino sequence is still able 
to undergo three steps of the original four in a single pot and could generate the azadiene 
requried for the Diels-Alder to occur. This sequence also addresses issues encountered in our 
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previous work. The route showed an inherent bias towards the syn diastereomer (3:1:1), even in 
the presence of an indole, while previous work done in the lab and by Williams showed 
preference for the anti transition state. Not only was there an inherent biased for the desired 
stereomer 6, but it was able to be exclusively produced with the sultam chiral auxiliary. 
Additionally, by having facial selectivity come from the dienophile, the chiral auxiliary is easily 
removed from the final product through methods such as the transesterification demonstrated in 
the synthesis. The most notable advantage of this strategy is the convergent nature of the 
synthesis. The key sequence brings three separate fragments together, rather than constructing an 
equivalent structure in a linear sequence or two fragments as we previous used. This strategy 
allows for a much wider diversity in fragment construction. 
Table 1. A Comparison of Current Brevianamide B Synthetic Routes 
Author Technique Employed Longest Linear 
Sequence 
Total Yield 
Williams Intramolecular  
Diels-Alder 
12 0.0082% 
Williams SN2’ 18 3.0% 
Simpkins Cationic Cascade 9 8.6% 
Scheerer Domino Sequence/ 
IMDA reaction 
10 5.8% 
 
A comparison of our synthetic route to others shows that it has competitive yields and brevity, 
while still producing enantiopure material. Additionally this route could be shortened by one step 
to produce racemic brevianamide in 9 steps.  
Conclusion 
 Outlined in this paper is a direct and novel strategy for the construction of enantiopure 
bicyclo[2.2.2]diazaoctane cores and its applications towards brevianamide B. The current route 
gives enantiopure “pre-brevianamide” in eight steps from commercially available proline with a 
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total yield of 7.2%. This yield is believed will be improved after refocused efforts on the 
processing of the azadiene 5. Good reactivity was seen with a variety of dienohpiles, although 
good diastereoselectivity was only seen in the presence of the chiral auxiliary. The divergent 
nature of the molecule allows for variability in the fragments used in its construction.  
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Experimental Procedures 
 
 
 
Diketopiperazine 1.
CH2Cl2 (86 ml) at 0 °C was added NEt3 (11.98 ml, 85.74 mmol) Followed by 1.1 equivalents of 
chloroacetyl chloride (1.1 equivalents, 3.72 g , 47.16 mmol) dropwise via syringe. The reaction 
mixture was allowed to warm to rt for 16 h. After warming to rt, the mixture was diluted with 
NaHCO3 and was extracted with CH2Cl2 (25 ml). The combined organic layers were washed 
with brine (25 ml), dried with NaSO4, filtered through celite, and concentrated in vacuo to afford 
a brown oil. (7.85 g, 38.17 mmol). To the brown oil (5.25 g, 25.53 mmol) dissolved in butanone 
(51 ml) at rt was added NaN3 (3.67 g, 50.89 mmol). The reaction vessel was fitted with a reflux 
condenser and heated at 80 °C for 20 h. The resulting product was filtered and concentrated in 
vacuo to afford a reddish-brown oil (5.37 g, 25.31 mmol). To the oil (1.97 g, 9.28 mmol) in 
anhydrous toluene (38 ml) was added 1.05 equivalents of PPh3 (2.55 g, 9.75 mmol). The reaction 
mixture was heated at 90 °C for 20 h. The resulting mixture was concentrated in vacuo and 
triturated with Et2O and hexanes in order to remove a bulk of the PPh3. The resulting residue was 
further purified by flash column chromatography on silica gel (elution: 1% MeOH to 10% 
MeOH in 50/50 ethyl acetate/toluene, 1% triethylamine). The resulting product was a light, 
yellow oil (1.43 g, 8.48 mmol, 80% yield, 3 steps). TLC (60% EtOAc in hexane), Rf: 0.2 
(CAM); []D25 = +102 °. IR (film): 2951, 2984, 2889, 2360, 2107, 1685, 1457, 1322, 1263, 1022, 
751, 673, 625, 573-1; 1H NMR (400 MHz, CDCl3) 4.21 (dd, J=9.5 Hz, 1.6Hz, 1H), 4.11 (d, J=4.9 
Hz, 1H) 4.03 (m, 1H), 3.68 (s, 3H), 3.47 (m, 1H), 2.03 (m, 1H), 1.83 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 166.4, 161.8, 56.5, 53.3, 52.3, 44.2, 29.3, 22.2; Exact mass calcd for 
C8H12N2O2[M+Na
+], 191.0791. Found 191.0790. 
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Azadiene 5.To Diketopiperazine 1 (2.29 mmol) in THF ( 16.7 mL) at  –78 °C was added 
LiHMDS (1.0M in THF, 1.1 equiv) dropwise over 5 min by syringe. After stirring for 15 min at 
–78 °C, the indole aldehyde (1.0 equiv) was added and the reaction was stirred for an additional 
15 min at –78 °C. Ac2O (1.3 equiv) was added and the cooling bath was removed.  The reaction 
mixture was stirred at rt for 2 hours. DBU (1.4 equiv) was added and the reaction was stirred at rt 
for 18 hours. The reaction was then quenched with 0.2 M HCl and extracted with EtOAc (3 x 
20ml). The combined organic layers were then washed with brine, dried with NaSO4, and 
concentrated in vacuo. The resulting residue was then recrystallized (hexanes in EtOAc) to 
afford the product (.380 g, 42% yield) as a yellow solid; TLC (100% EtOAc in hexanes), Rf: 
0.40 in CAM; IR (film)  2976.2, 2938.7, 1730.2, 1653.1, 1583.6, 1578.9, 1451.6, 1369.1, 1349.1, 
1256.181, 1156.8, 1079.8, 1046.2, 1016.2, 855.4, 749.6;  1H NMR (400 MHz, CDCl3) 8.10 
(s,1H), 7.75 (d, J=7.3, 1H), 7.61 (s,1H), 7.29-7.19 (m, 2H), 4.19 (s, 2H), 4.14 (t, J=7.0, 2H), 3.82 
(s, 3H), 3.04 (t, J=7.4, 2H), 2.21 (q, J=7.4, 2H), 2.05 ( s, 1H), 1.65 (s, 9H); 13C NMR (100 MHz, 
CDCl3)δ 153.9, 149.4, 142.5, 130.7, 125.4, 124.0, 122.1, 119.9, 116.6, 115.0, 83.2, 77.2, 54.7, 
49.5, 28.3, 28.1, 28.0, 21.5; Exact mass calculated for C22H25N3O4 [M+Na]
+, 418.1845, Found 
418.1743 
 
                                   
Acylated sultam 11 was prepared by alkylation of Bornane-2,10-sultam13 
 
Sultam Cycloadduct 12. To a flame dried flask, was added acylated sultam 11 (135 mg, 0.51 
mmol) and azadiene 5 (188 mg, .48 mmol). The flask was fitted with a condenser, purged with 
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N2, and the reactants were dissolved in DMF (3.18 ml, 0.15 M). The reaction was heated at 60 
°C for 24 h, cooled to rt, and concentrated in vacuo to afford a brown oil. Purification by flash 
column chromatography on silica gel (elution: 30% to 70% EtOAc in hexanes) afforded the 
desired product (260 mg, 0.31 mmol, 62% yield)TLC: (80% EtOAc in hexane), Rf: 0.3 (CAM); 
[]D25 = +59 °. IR (film): 3854, 3744, 3061, 2986, 2882, 2360, 2337, 1730 1683, 1648, 1635, 
1452, 1363, 1351, 1308, 1298, 1268, 1258, 1218, 1164, 1135, 1083, 1015, 987, 768, 735, 667, 
533 -1cm; 1H NMR (400 MHz, CDCl3) 8.1 (s, 1H), 7.77 (d, J=1.14 Hz, 1H), 7.66 (s, 1H), 7.23 
(m, 4H), 3.76 (s, 3H), 3.50 (d, J=3.1 Hz, 1H), 3.46 (t, J=7 Hz, 2H), 3.37 (t, J=13.1 Hz, 2H), 3.29 
(t, J=14.9 Hz, 2H), 2.09 (t, J=5.1 Hz, 2H), 2.04 (t, J=1.6 Hz, 2H), 1.99 (t, J=6.6 Hz, 2H), 1.93 (t, 
J=2 Hz, 2H), 1.85 (m, 2H), 1.70 (s, 3H), 1.68 (s, 3H), 1.66(s, 3H), 1.30 (m, 2H), 1.15 (s, 3H), 
0.96 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 172.2, 170.9, 169.5, 149.8, 135.1, 132.1, 125.5, 
123.6, 121.9, 120.4, 116.5, 114.8, 83.1, 66.3, 66.2, 65.4, 54.5, 53.1, 49.0 48.2, 47.7, 44.6, 43.2, 
38.5, 34.9, 32.9, 28.8, 28.2, 27.2, 26.3, 24.4, 20.9, 19.8; Exact mass calcd for 
C35H44N4O7S[M+Na
+], 687.2823. Found 687.2813. 
 
      
  
Ethyl Ester 14. To a flame dried flask, was added ethyl acrylate ( 114 mg, 1.14 mmol) and 
azadiene 5 (227 mg, .575 mmol). The flask was fitted with a condenser, purged with N2, and the 
reactants were dissolved in DMF (3.18 ml, 0.15 M). The reaction was heated at 60 °C for 24 h, 
cooled to rt, and concentrated in vacuo to afford a brown oil. Purification by flash column 
chromatography on silica gel (elution: 30% to 90% EtOAc in hexanes) afforded the desired 
product14a (183 mg, 0.109 mmol, 48% yield) and a minor diastereomer 14b (46 mg, 0.092 
mmols, 16% yield) 14a:TLC: (60% EtOAc in hexane), Rf: 0.3 (CAM);. IR (film): 2985, 2945, 
2876, 1736, 1683, 1642, 1456, 1456, 1416, 1308, 1260, 1156, 1085, 1016, 852, 768, 745 -1cm; 
1H NMR (400 MHz, CDCl3 ); 8.10 (s, 1H), 7.78 (d, J=7.5, 1H), 7.78 (s, 1H), 7.24 (m, 2H), 4.07 
(m, 2H), 3.74 (s, 3H), 3.40 (m, 4H), 2.78 (q, J=5.1, 1H), 2.61 (m, 1H), 2.00 (m, 4H), 1.80 (q, 
J=3.9, 1H), 1.56 (s, 9H), 1.18 (t, J= 7.2, 3H)13C NMR (100 MHz, CDCl3) δ172.3, 163.0, 160.8, 
149.5, 134.9, 132.1, 130.3, 129.0, 128.4, 128.2, 125.3, 124.7, 123.0, 118.9, 116.1, 155.5, 115.1, 
104.8, 83.7, 65.6, 60.7, 54.3, 43.8, 35.0, 32.4, 29.0, 28.2, 28.1, 20.2, 14.0 ; Exact mass calcd for 
C27H33N3O6[M+Na
+], 518.2261. Found 518.2259. 
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14b: TLC: (60% EtOAc in hexane), Rf: 0.20 (CAM);. IR (film): 2361, 1736, 1686, 1651, 1576, 
1456, 1370, 1254, 1148, 1083, 849, 751, 764, 705,-1cm; 1H NMR (400 MHz, CDCl3 ); 8.11 (s, 
1H), 7.81 (d, J=7.5, 1H), 7.68 (s, 1H), 7.26 (t, 1H, J=1.5), 7.19 (t, J= 6.8, 1H) 4.18 (m, 2H), 3.65 
(s, 3H), 3.54 (t, J=7.2, 3H), 2.75 (q, J=4.8, 1H), 2.57 (q, J=6.2, 1H), 1.95 (m, 5H), 1.65 (s, 9H), 
1.26 (t, J= 7.2, 3H)13C NMR (100 MHz, CDCl3) δ172.7, 172.6, 170.1, 125.4, 124.6, 123.7, 
122.9, ,121.7, 121.2, 116.5, 115.1, 114.7, 77.3, 68.9, 63.3, 61.2, 60.4, 57.2, 54.6, 45.1, 44.6, 43.4, 
36.2, 28.6, 28.2, 27.1, 24.6, 14.2, 14.1 ; Exact mass calcd for C27H33N3O6[M+Na
+], 518.2261. 
Found 518.2259. 
 
 
 
Benzyl Ester 13. To a flame dried flask, benzyl alcohol (13 µl, 0.12 mmol) in THF (0.6 ml) was 
added 3 M n-butyllithium (33 µl, .01 mmol) at -78 °C. To this solution was added a 0.5 M 
solution of the sultam cycloadduct (20 mg, 0.03 mmol) in THF was added to the solution and 
allowed to warm to 0 °C for 8 h. The reaction was quenched with ammonium chloride and 
concentrated. It was then partitioned with EtOAc and washed with sodium bicarbonate and brine. 
The solution was purified using flash column chromatography on silica gel (elution: 30% EtOAc 
to 70% EtOAc in hexanes) to afford a yellow oil (13 mg, 75% yield). TLC (60% EtOAc in 
hexane), Rf: 0.6 (CAM); []D25 = +25 °. IR (film): 2985, 2942, 2882, 2358, 2330, 1730, 1686, 
1639, 1452, 1370, 1308, 1257, 1160, 1085, 1015, 912, 857, 746, 668, 664 -1cm; 1H NMR (400 
MHz, CDCl3) 8.11 (s, 1H), 7.77 (d, J=8 Hz, 1H), 7.65 (s, 1H), 7.43-7.33 (m, 5H), 5.05 (d, 
J=12.1 Hz, 1H), 4.99 (d, J=12.1 Hz, 1H), 3.77 (d, J=6.7 Hz, 1H), 3.65 (s, 3H), 3.49 (m, 3H), 
3.46 (d, J=4.7 Hz, 1H), 3.35 (m, 2H), 2.85 (d, J=5.5 Hz, 1H), 2.82 (d, J=5.5 Hz, 1H) 2.58 (m, 
2H), 2.05 (s, 2H), 1.66 (s, 3H), 1.56 (s, 3H), 1.28 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 172.4, 
171.4, 169.6, 135.3, 132.3, 128.8, 125.8, 124.1, 122.3, 120.7, 116.7, 115.1, 83.4, 67.2, 66.6, 65.9, 
54.6, 49.3, 43.6, 34.2, 30.6, 29.1, 28.5, 28.4, 24.9, 13.8; Exact mass calcd for 
C32H35N3O6[M+Na
+], 580.2418. Found 580.2405. 
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Tertiary Alcohol 15.  Benzyl ester 13 (0.90g, .162 mmol) was dissolved in toluene (7.0 mL) and 
cooled to 0 oC. A 1.4 M solution of methyl magnesium bromide (3.5 equiv) was then added 
dropwise, and the reaction was left to react over 30 minutes. The reaction was then quenched 
with de-ionized water, diluted with NH4Cl and extracted with ethyl acetate (3x 10 ml). The 
combined organic layers where then washed with brine, dried with NaSO4, and concentrated in 
vacuo. Purification of the resulting residue by flash chromatography on silica gel (elution: 60% 
to 100% EtOAc in hexanes) afforded the desired product (.055 g, 0.114 mmol, 71% yield) as a 
clear oil: TLC (100% EtOAc in hexanes) Rf: 0.50 in CAM; []D25 = +9.84o ;IR (film) 3854.5, 
3744.9, 1844.3, 1772.9, 1730.1, 1695.9, 1576.3, 1452.2, 1368.8, 1308.3, 1257.2, 1084.7, 768.2; 
1H NMR (400 MHz, CDCl3) 8.11(s, 1H), 7.79 (d, J= 7.4, 1H), 7.68 (S, 1H), 7.33-7.19 (m, 2H), 
3.72 (s, 3H), 3.59 (t, J=8.2, 1H), 3.42 (d, J=4.9, 1H), 3.30 (T, J=7.7, 2H), 3.21 (m, 3H), 2.61 (m, 
1H), 2.30 (m, 1H), 2.06 (m, 5H), 1.64 (s, 9H), 1.04 (s, 3H), 2.96 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ128.9, 128.1, 125.2, 125.1, 123.7, 122.0, 116.9, 120.2, 116.9, 114.8, 72.7, 66.9, 65.7, 
54.6, 54.1, 43.0, 33.6, 30.0, 29.7, 29.7, 29.1, 28.2, 28.1, 25.5, 24.9; Exact mass calculated for 
C27H35N3O5 [M+Na
+] 482.2577, Found 488.214 
 
         
Prebrevianamide 16. A solution of the tertiary alcohol (0.100g, 0.208 mmol) in 1:1 
dioxane/concentrated HCl was stirred under N2 at 0 
oC for 8 hours and then room temperature for 
16 hours. The reaction mixture was diluted with de-ionized water, made basic with 1M NaOH, 
and extracted with chloroform (5 x 10 ml). The combined organic layers were then washed with 
brine, dried with NaSO4, and concentrated under reduced pressure. Purification by flash 
chromatography (elution 3-5% MeOH in CHCl3) afforded the desired product as a white solid 
(0.049g, .135 mmol, 64.9% Rf: 0.40; []D25 = +25.83 °. IR (film) 3854.5, 3801.8, 3744.9, 
3382.5, 2975.4, 2358.9, 1844.3, 1751.5, 1684.7, 1616.8, 1576.3, 1456.9, 1436.8, 1010.5, 744.0, 
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667.6; 1H NMR (400 MHz, CDCl3) 8.59 (s, 1H), 7.61 (d, J=7.82, 1H), 7.28 (d, J= 7.82, 1H), 
7.23-7.10 (m, 3H), 6.15 (s, 1H), 3.64 (t, J=9.34, 1H), 3.56 (d, J=15.24, 1H), 3.23-3.17 (m, 1H),  
3.16 (s, 1H), 2.83-2.75 (m, 1H), 2.21-2.05 (m, 4H), 2.00-1.90 ( m, 1H), 1.74 (s, 2H), 1.22 (s, 
3H), 1.11 (s, 1H); 13C NMR (100 MHz, CdCl3) δ172.7, 170.3, 136.1, 128.1, 124.7, 122.2, 120.0, 
118.2, 111.5, 108.4, 7.205, 72.3, 69.3, 60.8, 53.9, 43.5, 36.5, 30.6, 29.8, 27.4, 26.3, 25.5; Exact 
mass calculated for C22H25N3O2 [M+H]
+, 350.1790, Found 351.1859 
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